ArticleAmerican journal of respiratory and critical care medicine2020
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials.
Ibrahim Abubakar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.